Prot #Q702-ONC-P1-US001: A Phase 1, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic, Pharmacokinetic Study of Q702 with a Cohort Expansion at the RP2D in Patients with Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date1/20/211/20/24

Funding

  • Translational Drug Development, LLC (Prot #Q702-ONC-P1-US001)
  • Qurient Co. Ltd. (Prot #Q702-ONC-P1-US001)